Inotek CEO David Southwell and William K. McVicar Ph.D. Executive Vice President, Chief Scientific Officer, share Inotek’s plan to bring to market a new first-line for glaucoma sufferers.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
